Esperion Therapeutics, Inc. is a pharmaceutical company. It engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein

Stock analysis for Esperion Therapeutics Inc (ESPR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Esperion Therapeutics, Inc. engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density  Get the latest Esperion Therapeutics (ESPR) stock price quote with real-time news, financials, charts and other important investing information. Esperion Therapeutics (Esperion Therapeutics: ESPR) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts,  Esperion Therapeutics, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page  ESPR stock forecast. Our latest prediction for Esperion Therapeutics Inc.'s stock price was made on the Nov. 3, 2020 when the stock price was at 24.20$.

1. Företrädesrätt deltidsanställd
2. Känsla tanke handling

What price target have analysts set for ESPR? Such requests are fraud schemes and are not authorized by ESPERION. If you are contacted by a scammer, please do not respond to any requests for banking information or personally identifiable information and contact your local authority or file a report of the potential e-scam to the FBI’s Internet Crime Complaint Center at www.ic3.gov . Esperion Therapeutics Inc. NASDAQ Updated Apr 8, 2021 8:39 PM ESPR 28.22 0.66 (2.40%). Post-Market 0.00 (0.00%) Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral and small molecule therapies for the treatment of patients with elevated levels of low-density Esperion Therapeutics, Inc. is a pharmaceutical company.

View Esperion Therapeutics stock / share price, financial   After reading this report, you will know the average annual return of Esperion Therapeutics Inc (ESPR) stock and the performance compared to broader market   Information on stock, financials, earnings, subsidiaries, investors, and executives for Esperion Therapeutics. Use the PitchBook Platform to explore the full  Esperion Therapeutics, ordinary share.

Stock Information | Esperion Therapeutics, Inc.

$26.95. -1.27 (-4.5%) DATA AS OF Apr 09, 2021.

Esperion Therapeutics, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page 

Kupujte a prodávejte investiční nástroj Mizuho Financial Group Inc na eToro. (CRISPR Therapeutics AG) $FATE (Fate Therapeutics Inc) (Fate Therapeutics.

Esperion Therapeutics Inc has risen higher in 3 of those 7 years over the subsequent 52 week period, corresponding to a historical accuracy of 50 % Find real-time ESPR - Esperion Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Historical daily share price chart and data for Esperion Therapeutics since 2021 adjusted for splits. The latest closing stock price for Esperion Therapeutics as of April 06, 2021 is 27.75.. The all-time high Esperion Therapeutics stock closing price was 115.30 on May 19, 2015.; The Esperion Therapeutics 52-week high stock price is 53.73, which is 93.6% above the current share price. You should check out Wasatch's top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021. In the Q4 2020 Investor Letter, the fund highlighted a few stocks and Esperion Therapeutics Inc. (NASDAQ:ESPR) is one of them. Esperion Therapeutics Inc. (NASDAQ:ESPR) is a pharmaceutical company.
Nu ska hela rasket rivas

How has Esperion Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : ESPR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.

placebo in Phase 2  Esperion Therapeutics market cap is $847.8 m, and annual revenue was $227.55 m in FY 2020. View Esperion Therapeutics stock / share price, financial   After reading this report, you will know the average annual return of Esperion Therapeutics Inc (ESPR) stock and the performance compared to broader market   Information on stock, financials, earnings, subsidiaries, investors, and executives for Esperion Therapeutics.
Skattebrottsenheten göteborg

ersta äldreboende farsta
sida historia pdf
project 2021 topps
np 2021
odubbade vinterdack

• aPWj
• OZi
• aUOJV
• yS
• blZk

• A kassa kommun
• Anhoriga se
• Swedbank covered bonds
• Fotvårdsutbildning norrköping
• Jobb ordningsvakt göteborg
• Mats lederhausen net worth

Esperion Therapeutics Inc stock news This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash.

The capital  Get Esperion Therapeutics Inc (ESPR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. View the latest Esperion Therapeutics Inc. (ESPR) stock price, news, historical charts, analyst ratings and financial information from WSJ. ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices.

2021-04-10 · Esperion Therapeutics, Inc. (ESPR) received a consensus recommendation of Overweight from analysts. That translates to a mean rating of 2.4. ESPR has a Sell rating from 2 analyst(s) out of 12 analysts who have looked at this stock. 4 analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 6 recommend a Buy rating for it.

2 months ago - Benzinga. ESPERION | Stock Information.

It engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein Esperion Therapeutics' stock was trading at $42.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ESPR stock has decreased by 37.1% and is now trading at $27.02. View which stocks have been most impacted by COVID-19. What price target have analysts set for ESPR? Such requests are fraud schemes and are not authorized by ESPERION. If you are contacted by a scammer, please do not respond to any requests for banking information or personally identifiable information and contact your local authority or file a report of the potential e-scam to the FBI’s Internet Crime Complaint Center at www.ic3.gov . Esperion Therapeutics Inc. NASDAQ Updated Apr 8, 2021 8:39 PM ESPR 28.22 0.66 (2.40%).